{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:24:53Z","timestamp":1789579493313,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.mri.2019.04.010","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T01:42:59Z","timestamp":1555638179000},"page":"110-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Hepatic complications of oral contraceptive pills and estrogen on MRI: Controversies and update - Adenoma and beyond"],"prefix":"10.1016","volume":"60","author":[{"given":"Janardhana","family":"Ponnatapura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6887-5266","authenticated-orcid":false,"given":"Ania","family":"Kielar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.B.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-Rahman","family":"Abualruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafel","family":"Tappouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5514-2805","authenticated-orcid":false,"given":"Neeraj","family":"Lalwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mri.2019.04.010_bb0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ajg.2013.406","article-title":"A comprehensive analysis of common genetic variation around six candidate loci for intrahepatic cholestasis of pregnancy","volume":"109","author":"Dixon","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.mri.2019.04.010_bb0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF02598014","article-title":"Hepatobiliary complications of oral contraceptives","volume":"7","author":"Lindberg","year":"1992","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.mri.2019.04.010_bb0015","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/j.2040-4603.2013.tb00519.x","article-title":"Bile formation and secretion","volume":"3","author":"Boyer","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1016\/j.mri.2019.04.010_bb0020","series-title":"Sleisenger and Fordtran's gastrointestinal and liver disease review and assessment","author":"DiMarino","year":"2010"},{"issue":"6","key":"10.1016\/j.mri.2019.04.010_bb0025","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0016-5085(72)80087-8","article-title":"Pregnancy, oral contraceptives, and chronic familial jaundice with predominantly conjugated hyperbilirubinemia (Dubin-Johnson syndrome)","volume":"62","author":"Cohen","year":"1972","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mri.2019.04.010_bb0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.22995","article-title":"Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience","volume":"50","author":"Bioulac-Sage","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mri.2019.04.010_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000268406","article-title":"Subtype classification of hepatocellular adenoma","volume":"27","author":"Bioulac-Sage","year":"2010","journal-title":"Dig Surg"},{"issue":"2","key":"10.1016\/j.mri.2019.04.010_bb0040","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2016.04.001","article-title":"EASL clinical practice guidelines on the management of benign liver tumours","volume":"65","author":"European Association for the Study of the L","year":"2016","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.mri.2019.04.010_bb0045","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/ajg.2014.213","article-title":"ACG clinical guideline: the diagnosis and management of focal liver lesions","volume":"109","author":"Marrero","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.mri.2019.04.010_bb0050","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1148\/radiol.11110023","article-title":"Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification","volume":"261","author":"van Aalten","year":"2011","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.mri.2019.04.010_bb0055","first-page":"877","article-title":"Hepatic adenomas: imaging and pathologic findings","volume":"21","author":"Grazioli","year":"2001"},{"issue":"25","key":"10.1016\/j.mri.2019.04.010_bb0060","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.4254\/wjh.v7.i25.2603","article-title":"Hepatocellular adenoma: an update","volume":"7","author":"Vijay","year":"2015","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.mri.2019.04.010_bb0065","first-page":"140","article-title":"Telangiectatic adenoma: an entity associated with increased body mass index and inflammation","volume":"46","author":"Paradis","year":"2007"},{"key":"10.1016\/j.mri.2019.04.010_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/374170","article-title":"MR imaging of hepatocellular adenomas and differential diagnosis dilemma","volume":"2013","author":"Grazioli","year":"2013","journal-title":"Int J Hepatol"},{"issue":"2","key":"10.1016\/j.mri.2019.04.010_bb0080","first-page":"433","article-title":"Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings","volume":"241","author":"Lewin","year":"2006"},{"issue":"4","key":"10.1016\/j.mri.2019.04.010_bb0085","doi-asserted-by":"crossref","first-page":"W408","DOI":"10.2214\/AJR.13.12251","article-title":"Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI","volume":"203","author":"Agarwal","year":"2014","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.mri.2019.04.010_bb0090","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.22417","article-title":"Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification","volume":"48","author":"Laumonier","year":"2008","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.mri.2019.04.010_bb0095","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3748\/wjg.v13.i19.2649","article-title":"Genotype phenotype classification of hepatocellular adenoma","volume":"13","author":"Bioulac-Sage","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.mri.2019.04.010_bb0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/2156-7514.163991","article-title":"Malignant transformation of hepatic adenoma in glycogen storage disease type-1a: report of an exceptional case diagnosed on surveillance imaging","volume":"5","author":"Baheti","year":"2015","journal-title":"J Clin Imaging Sci"},{"issue":"12","key":"10.1016\/j.mri.2019.04.010_bb0105","first-page":"740","article-title":"Beta-catenin staining of hepatocellular adenomas","volume":"13","author":"Garcia-Buitrago","year":"2017","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"8","key":"10.1016\/j.mri.2019.04.010_bb0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1477-2574.2010.00222.x","article-title":"Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases","volume":"12","author":"Stoot","year":"2010","journal-title":"HPB Off J Int Hepato Pancreato Biliary Assoc"},{"issue":"1","key":"10.1016\/j.mri.2019.04.010_bb0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000268405","article-title":"Malignant transformation of liver adenoma: an analysis of the literature","volume":"27","author":"Farges","year":"2010","journal-title":"Dig Surg"},{"issue":"1","key":"10.1016\/j.mri.2019.04.010_bb0120","first-page":"104","article-title":"Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid\u2013enhanced MR imaging","volume":"277","author":"Ba-Ssalamah","year":"2015"},{"issue":"9","key":"10.1016\/j.mri.2019.04.010_bb0125","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s11604-012-0115-2","article-title":"Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8","volume":"30","author":"Yoneda","year":"2012","journal-title":"Jpn J Radiol"},{"issue":"1","key":"10.1016\/j.mri.2019.04.010_bb0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1148\/radiol.2015142366","article-title":"Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid-enhanced MR imaging","volume":"277","author":"Ba-Ssalamah","year":"2015","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.mri.2019.04.010_bb0140","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/j.gastro.2016.11.042","article-title":"Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation","volume":"152","author":"Nault","year":"2017","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.mri.2019.04.010_bb0145","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/modpathol.2015.83","article-title":"Pigmented hepatocellular adenomas have a high risk of atypia and malignancy","volume":"28","author":"Mounajjed","year":"2015","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.mri.2019.04.010_bb0150","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.path.2018.02.007","article-title":"Hepatic adenomas","volume":"11","author":"Torbenson","year":"2018","journal-title":"Surg Pathol Clin"},{"issue":"3","key":"10.1016\/j.mri.2019.04.010_bb0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10353-018-0536-y","article-title":"Indications for liver surgery in benign tumours","volume":"50","author":"Fodor","year":"2018","journal-title":"Eur Surg"},{"issue":"5","key":"10.1016\/j.mri.2019.04.010_bb0160","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/0016-5085(85)90220-3","article-title":"Liver adenomatosis. An entity distinct from liver adenoma?","volume":"89","author":"Flejou","year":"1985","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mri.2019.04.010_bb0165","first-page":"395","article-title":"Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients","volume":"216","author":"Grazioli","year":"2000"},{"issue":"3","key":"10.1016\/j.mri.2019.04.010_bb0170","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0016-5085(00)70262-9","article-title":"Oral contraceptive use and focal nodular hyperplasia of the liver","volume":"118","author":"Mathieu","year":"2000","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.mri.2019.04.010_bb0175","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000268404","article-title":"Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology","volume":"27","author":"Maillette de Buy Wenniger","year":"2010","journal-title":"Dig Surg"},{"issue":"3","key":"10.1016\/j.mri.2019.04.010_bb0180","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/jmri.22833","article-title":"Hepatobiliary MR imaging with gadolinium-based contrast agents","volume":"35","author":"Frydrychowicz","year":"2012","journal-title":"J Magn Reson Imaging JMRI"},{"issue":"2","key":"10.1016\/j.mri.2019.04.010_bb0185","first-page":"413","article-title":"Focal nodular hyperplasia and hepatocellular adenoma: accuracy of gadoxetic acid\u2013enhanced MR imaging\u2014a systematic review","volume":"277","author":"McInnes","year":"2015"},{"key":"10.1016\/j.mri.2019.04.010_bb0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mri.2017.12.006","article-title":"Inflammatory hepatic adenomas: characterization with hepatobiliary MRI contrast agents","volume":"47","author":"Glockner","year":"2018","journal-title":"Magn Reson Imaging"},{"issue":"7","key":"10.1016\/j.mri.2019.04.010_bb0195","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.7150\/jca.17778","article-title":"Diagnostic value of Gd-EOB-DTPA-MRI for hepatocellular adenoma: a meta-analysis","volume":"8","author":"Guo","year":"2017","journal-title":"J Cancer"},{"issue":"2","key":"10.1016\/j.mri.2019.04.010_bb0200","first-page":"465","article-title":"Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases","volume":"228","author":"Attal","year":"2003"},{"issue":"9","key":"10.1016\/j.mri.2019.04.010_bb0205","first-page":"1414","article-title":"Liver masses: a clinical, radiologic, and pathologic perspective","volume":"12","author":"Venkatesh","year":"2014","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"6","key":"10.1016\/j.mri.2019.04.010_bb0210","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2214\/ajr.179.6.1791457","article-title":"CT and MR imaging features of pathologically proven atypical giant hemangiomas of the liver","volume":"179","author":"Coumbaras","year":"2002","journal-title":"Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.mri.2019.04.010_bb0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00000658-198802000-00001","article-title":"Recurrent hepatic hemangiomas. Possible association with estrogen therapy","volume":"207","author":"Conter","year":"1988","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.mri.2019.04.010_bb0220","first-page":"1199","article-title":"Oral contraceptives and liver hemangioma: a case-control study","volume":"83","author":"Gemer","year":"2004"},{"issue":"5922","key":"10.1016\/j.mri.2019.04.010_bb0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmj.3.5922.7","article-title":"Liver hamartomas in patients on oral contraceptives","volume":"3","author":"O'Sullivan","year":"1974","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.mri.2019.04.010_bb0230","first-page":"221","article-title":"Liver tumors in women on contraceptive steroids","volume":"46","author":"Christopherson","year":"1975","journal-title":"Obstet Gynecol"},{"issue":"7 Part 2","key":"10.1016\/j.mri.2019.04.010_bb0235","first-page":"2584","article-title":"Sex hormones and hepatic neoplasia","volume":"36","author":"Goldfarb","year":"1976","journal-title":"Cancer Res"},{"issue":"43","key":"10.1016\/j.mri.2019.04.010_bb0240","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001619","article-title":"Oral contraceptives use and liver cancer risk: a dose-response meta-analysis of observational studies","volume":"94","author":"An","year":"2015","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.mri.2019.04.010_bb0245","first-page":"440S","article-title":"Hepatocellular carcinoma in women: probable lack of etiologic association with oral contraceptive steroids","volume":"2","author":"Goodman","year":"1982"},{"issue":"1","key":"10.1016\/j.mri.2019.04.010_bb0250","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.2214\/AJR.13.11511","article-title":"Hepatocellular carcinoma in the noncirrhotic liver","volume":"203","author":"Gaddikeri","year":"2014","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.mri.2019.04.010_bb0255","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/2050640615582293","article-title":"Budd-Chiari syndrome","volume":"3","author":"Martens","year":"2015","journal-title":"United Eur Gastroenterol J"},{"issue":"3","key":"10.1016\/j.mri.2019.04.010_bb0260","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0168-8278(00)80290-1","article-title":"Budd-Chiari syndrome: combination of genetic defects and the use of oral contraceptives leading to hypercoagulability","volume":"33","author":"Minnema","year":"2000","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.mri.2019.04.010_bb0265","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0168-8278(00)80259-7","article-title":"Portal vein thrombosis in adults: pathophysiology, pathogenesis and management","volume":"32","author":"Valla","year":"2000","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.mri.2019.04.010_bb0270","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2214\/AJR.12.9098","article-title":"Budd-Chiari syndrome","volume":"199","author":"Ferral","year":"2012","journal-title":"Am J Roentgenol"},{"issue":"10","key":"10.1016\/j.mri.2019.04.010_bb0275","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1136\/gut.2007.133637","article-title":"Budd\u2013Chiari syndrome and veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"57","author":"Valla","year":"2008","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.mri.2019.04.010_bb0280","first-page":"572","article-title":"Generalized peliosis hepatis and cirrhosis after long-term use of oral contraceptives","volume":"83","author":"van Erpecum","year":"1988","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mri.2019.04.010_bb0285","series-title":"MacSween's pathology of the liver","first-page":"601","article-title":"12 - vascular disorders","author":"Wanless","year":"2012"},{"issue":"1","key":"10.1016\/j.mri.2019.04.010_bb0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.forsciint.2004.05.010","article-title":"Pathology of peliosis","volume":"149","author":"Tsokos","year":"2005","journal-title":"Forensic Sci Int"},{"issue":"11","key":"10.1016\/j.mri.2019.04.010_bb0295","first-page":"2343","article-title":"Chronic liver injury induced by drugs: a systematic review","volume":"35","author":"Stine","year":"2015"},{"issue":"1","key":"10.1016\/j.mri.2019.04.010_bb0300","first-page":"41","article-title":"Generalised peliosis hepatis mimicking metastases after long-term use of oral contraceptives","volume":"73","author":"Kootte","year":"2015","journal-title":"Neth J Med"},{"issue":"4","key":"10.1016\/j.mri.2019.04.010_bb0305","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3350\/cmh.2015.21.4.387","article-title":"Peliosis hepatis presenting with massive hepatomegaly in a patient with idiopathic thrombocytopenic purpura","volume":"21","author":"Kim","year":"2015","journal-title":"Clin Mol Hepatol"},{"issue":"46","key":"10.1016\/j.mri.2019.04.010_bb0310","doi-asserted-by":"crossref","first-page":"13188","DOI":"10.3748\/wjg.v21.i46.13188","article-title":"Peliosis hepatis: personal experience and literature review","volume":"21","author":"Crocetti","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.mri.2019.04.010_bb0315","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3350\/cmh.2015.21.4.398","article-title":"Focal type of peliosis hepatis","volume":"21","author":"Hong","year":"2015","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"10.1016\/j.mri.2019.04.010_bb0320","doi-asserted-by":"crossref","first-page":"W43","DOI":"10.2214\/AJR.05.0167","article-title":"Peliosis hepatis: spectrum of imaging findings","volume":"187","author":"Iannaccone","year":"2006","journal-title":"Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.mri.2019.04.010_bb0325","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4236\/ojrad.2014.41010","article-title":"Unique MR findings in a case series of two symptomatic patients with peliosis hepatis","author":"Pierce","year":"2014","journal-title":"Open J Radiol"}],"container-title":["Magnetic Resonance Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X18305836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X18305836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:32:13Z","timestamp":1759998733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0730725X18305836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":63,"alternative-id":["S0730725X18305836"],"URL":"https:\/\/doi.org\/10.1016\/j.mri.2019.04.010","relation":{},"ISSN":["0730-725X"],"issn-type":[{"value":"0730-725X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic complications of oral contraceptive pills and estrogen on MRI: Controversies and update - Adenoma and beyond","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mri.2019.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}